Aegerion Pharmaceuticals announces third-quarter 2014 financial results
Aegerion reported the GAAP net loss was $5.9 million, or $0.20 per share in the 2014 third quarter versus a GAAP net loss of $12.5 million, or $0.43 per share, for the same period in 2013. Net product sales for the 2014 third-quarter were $43.7 million versus $16.3 million in the 2013 third-quarter. October 30, 2014